CCND1 and hematologic disorder: This recurrent chromosomal alteration juxtaposes the CCND1 gene with the IgH-5 Eμ enhancer located at 14q34.2, leading to dysregulation of CCND1 gene expression, which is considered a key molecular event in the development of hematological malignancies with the t(11;14) (6).